Department of Conservative Dentistry, Oral Pathology and Maxillofacial Surgery, Catholic University of Leuven, Belgium.
J Adhes Dent. 2010 Apr;12(2):151-61. doi: 10.3290/j.jad.a17547.
The aim of this prospective randomized controlled clinical trial was to evaluate the 2-year clinical performance of a self-adhesive resin cement, RelyX Unicem (3M ESPE), used for cementation of ceramic inlays. In addition, the influence of selectively acid etching enamel prior to luting on marginal integrity, inlay integrity, tooth integrity, sensitivity, and complications of the restored teeth was assessed. The hypothesis tested was that there was no significant difference in these criteria between restorations with (Etch) or without prior enamel acid etching (Non-etch).
Sixty-two IPS Empress 2 inlays/onlays were placed in 31 patients by two experienced clinicians. The restorations were luted with RelyX Unicem with (=experimental group; Etch) or without (=control group; Non-etch) prior enamel etching with phosphoric acid. At baseline, 6 months, 1 year and 2 years after placement, the restorations were assessed by two calibrated investigators using modified USPHS criteria.
The recall rate at 24 months was 96.6%. Two restorations were clinically unacceptable due to loss of retention, leading to a survival rate of 96.6% (Kaplan-Meier). No significant difference was noted between the experimental group and the control group regarding marginal integrity, inlay integrity, tooth integrity, complications and sensitivity (McNemar, p > 0.05). An obvious deterioration in marginal adaptation was observed after 24 months as only 21.7% (Etch = 23.4%; Non-etch = 20%) of the restorations exhibited an excellent marginal adaptation compared to 70.7% (Etch = 75%; Non-etch = 66.7%) at baseline. In 74.9% of the restorations, small, still clinically acceptable marginal deficiencies were observed (Etch = 76.6%; Non-etch = 73.2%).
The self-adhesive resin cement RelyX Unicem showed acceptable clinical behavior after two years of clinical service. Selective enamel etching prior to luting had no significant influence on marginal integrity, inlay integrity, tooth integrity, sensitivity or complications of the restored teeth after 24 months. Longer term evaluation is needed to confirm this finding.
本前瞻性随机对照临床试验旨在评估自粘接树脂水门汀 RelyX Unicem(3M ESPE)用于黏固陶瓷嵌体的 2 年临床性能。此外,评估在黏固前选择性酸蚀釉质对边缘完整性、嵌体完整性、牙体完整性、敏感性和修复牙并发症的影响。检验的假设是,在这些标准中,具有(酸蚀)或不具有预先酸蚀釉质(非酸蚀)的修复体之间没有显著差异。
由两位经验丰富的临床医生将 62 个 IPS Empress 2 嵌体/高嵌体放置在 31 位患者中。修复体用 RelyX Unicem 黏固,其中(实验组;酸蚀)或不用(对照组;非酸蚀)磷酸酸蚀预先酸蚀釉质。在基线、6 个月、1 年和 2 年后,由两位经过校准的研究者使用改良的 USPHS 标准进行评估。
24 个月的召回率为 96.6%。由于固位丧失,有 2 个修复体临床不可接受,导致存活率为 96.6%(Kaplan-Meier)。实验组和对照组在边缘完整性、嵌体完整性、牙体完整性、并发症和敏感性方面无显著差异(McNemar,p>0.05)。24 个月后,边缘适应性明显恶化,只有 21.7%(酸蚀=23.4%;非酸蚀=20%)的修复体显示出优异的边缘适应性,而基线时为 70.7%(酸蚀=75%;非酸蚀=66.7%)。在 74.9%的修复体中,观察到较小的、仍在临床可接受的边缘缺陷(酸蚀=76.6%;非酸蚀=73.2%)。
自粘接树脂水门汀 RelyX Unicem 在临床使用 2 年后表现出可接受的临床行为。在黏固前选择性酸蚀釉质对 24 个月后的边缘完整性、嵌体完整性、牙体完整性、敏感性或修复牙并发症没有显著影响。需要进行更长时间的评估以证实这一发现。